Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.88M | $160.0M | 22.32% | -- | 2026-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4.89M | $43.0M | 6.10% | -- | 2026-03-31 |
| Omega Fund Management, LLC | 3.29M | $29.0M | 4.11% | -- | 2026-03-31 |
| Alphabet Inc. | 2.82M | $25.0M | 3.52% | -- | 2026-03-31 |
| EcoR1 Capital, LLC | 2.82M | $25.0M | 3.52% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.82M | $25.0M | 3.52% | -88.7K | 2026-03-31 |
| ENAVATE SCIENCES GP, LLC | 2.63M | $23.0M | 3.28% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 2.53M | $22.0M | 3.16% | -1.6K | 2026-03-31 |
| NOVO HOLDINGS A/S | 2.19M | $19.0M | 2.73% | +224.6K | 2026-03-31 |
| BlackRock, Inc. | 2.09M | $18.0M | 2.61% | +3.5K | 2026-03-31 |
